| Michael Hayashi, MD | |
|
1356 Lusitana St Fl 6, Department Of Surgery, Honolulu, HI 96813-2409 | |
| (808) 586-2920 | |
| (808) 586-3022 |
| Full Name | Michael Hayashi |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 21 Years |
| Location | 1356 Lusitana St Fl 6, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699976308 | NPI | - | NPPES |
| 15572 | Other | HI | HAWAII MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 15572 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Queens Medical Center | Honolulu, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Queens University Medical Group | 2466831557 | 543 |
News Archive
Over the past three years, more than 20,000 students at 135 schools in Washington State have participated in the Science Adventure Lab program, an initiative launched by Seattle Children's Research Institute in 2009.
Once damaged, the human heart does a poor job of repairing itself, so this is a key priority for treating heart failure. One way of restoring cardiac function is to reprogram non-cardiac body cells such as fibroblasts into heart muscle cells (cardiomyocytes) using a collection of cardiac transcription factors.
The first new TB vaccine for more than 80 years has successfully come through safety trials in the UK. The vaccine, devised by a team led by Dr Helen McShane in Oxford's Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), is designed to be used in tandem with the tried and tested BCG inoculation – first introduced in 1921 – and not to replace it.
A team of scientists from Spain has recently evaluated the efficacy of an mRNA-based COVID-19 vaccine developed by Pfizer-BioNTech (BNT162b2). Their findings reveal that a 2-dose regimen of BNT162b2 vaccine is capable of providing almost 100% protection against SARS-CoV-2 infection in healthcare workers.
› Verified 5 days ago
| Entity Name | The Queens Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487693586 PECOS PAC ID: 3476454067 Enrollment ID: O20040116000366 |
News Archive
Over the past three years, more than 20,000 students at 135 schools in Washington State have participated in the Science Adventure Lab program, an initiative launched by Seattle Children's Research Institute in 2009.
Once damaged, the human heart does a poor job of repairing itself, so this is a key priority for treating heart failure. One way of restoring cardiac function is to reprogram non-cardiac body cells such as fibroblasts into heart muscle cells (cardiomyocytes) using a collection of cardiac transcription factors.
The first new TB vaccine for more than 80 years has successfully come through safety trials in the UK. The vaccine, devised by a team led by Dr Helen McShane in Oxford's Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), is designed to be used in tandem with the tried and tested BCG inoculation – first introduced in 1921 – and not to replace it.
A team of scientists from Spain has recently evaluated the efficacy of an mRNA-based COVID-19 vaccine developed by Pfizer-BioNTech (BNT162b2). Their findings reveal that a 2-dose regimen of BNT162b2 vaccine is capable of providing almost 100% protection against SARS-CoV-2 infection in healthcare workers.
› Verified 5 days ago
| Entity Name | Queens University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891441382 PECOS PAC ID: 2466831557 Enrollment ID: O20220621000534 |
News Archive
Over the past three years, more than 20,000 students at 135 schools in Washington State have participated in the Science Adventure Lab program, an initiative launched by Seattle Children's Research Institute in 2009.
Once damaged, the human heart does a poor job of repairing itself, so this is a key priority for treating heart failure. One way of restoring cardiac function is to reprogram non-cardiac body cells such as fibroblasts into heart muscle cells (cardiomyocytes) using a collection of cardiac transcription factors.
The first new TB vaccine for more than 80 years has successfully come through safety trials in the UK. The vaccine, devised by a team led by Dr Helen McShane in Oxford's Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), is designed to be used in tandem with the tried and tested BCG inoculation – first introduced in 1921 – and not to replace it.
A team of scientists from Spain has recently evaluated the efficacy of an mRNA-based COVID-19 vaccine developed by Pfizer-BioNTech (BNT162b2). Their findings reveal that a 2-dose regimen of BNT162b2 vaccine is capable of providing almost 100% protection against SARS-CoV-2 infection in healthcare workers.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Hayashi, MD 1356 Lusitana St Fl 6, Department Of Surgery, Honolulu, HI 96813-2409 Ph: (808) 586-2920 | Michael Hayashi, MD 1356 Lusitana St Fl 6, Department Of Surgery, Honolulu, HI 96813-2409 Ph: (808) 586-2920 |
News Archive
Over the past three years, more than 20,000 students at 135 schools in Washington State have participated in the Science Adventure Lab program, an initiative launched by Seattle Children's Research Institute in 2009.
Once damaged, the human heart does a poor job of repairing itself, so this is a key priority for treating heart failure. One way of restoring cardiac function is to reprogram non-cardiac body cells such as fibroblasts into heart muscle cells (cardiomyocytes) using a collection of cardiac transcription factors.
The first new TB vaccine for more than 80 years has successfully come through safety trials in the UK. The vaccine, devised by a team led by Dr Helen McShane in Oxford's Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), is designed to be used in tandem with the tried and tested BCG inoculation – first introduced in 1921 – and not to replace it.
A team of scientists from Spain has recently evaluated the efficacy of an mRNA-based COVID-19 vaccine developed by Pfizer-BioNTech (BNT162b2). Their findings reveal that a 2-dose regimen of BNT162b2 vaccine is capable of providing almost 100% protection against SARS-CoV-2 infection in healthcare workers.
› Verified 5 days ago
Huseyin Akin Erol, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1356 Lusitana St Fl 6, Honolulu, HI 96813 Phone: 979-571-6231 | |
Jessica Green, Surgery Medicare: Accepting Medicare Assignments Practice Location: 888 S King St, Honolulu, HI 96813 Phone: 808-522-4469 | |
Dr. Justin M. Galovich, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Dr. Cedric San Felipe Lorenzo, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1329 Lusitana St Ste 304, Honolulu, HI 96813 Phone: 808-566-6723 | |
Dr. Elna M. Masuda, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 888 S King St, Honolulu, HI 96813 Phone: 808-522-4000 Fax: 808-522-4523 | |
Dr. Katie H.t. Huang, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 888 S King St, Honolulu, HI 96813 Phone: 808-522-4000 Fax: 808-522-4397 | |
Dr. Patrick Paul Pedro, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 550 S Beretania St, Suite #501, Honolulu, HI 96813 Phone: 808-528-4144 Fax: 808-525-6868 |